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Development of an Instrument based on the Protection
and Glanz, 2005) . In the Protection Motivation Theory (PMT), it is assumed that protection motivation (i.e. the individual's intention to perform a behavior) results from the two appraisal processes and is a positive function of severity, vulnerability, self-efficacy, and response efficacy, and a negative function of the rewards associated with maladaptive responses and the response costs of the adaptive behavior. Reasons for not ever attending a Pap smear are different with failing to it continue in further. Evidence has shown that women with previous Pap smear experiences are more likely to repeat it in the future (Abdullah et al., 2001; Fernandez, and Chen, 2003; Gu et al, 2012; Hou) . It seems that these women are more health-conscious and believe in the advantages of the Pap test (Abdullah et al., 2001) .
In the past studies was surveyed factor influencing to receive future screening (secondary and subsequent Pap smear) (Gu et al., 2012) . To our knowledge, little is known about motivations and personal potential variables that contribute to women's intention to have their first Pap smear test done (Twinn and Cheng, 2000; Austin et al., 2002) . Understanding these factors may result in designing tailored educational interventions and an increase in the number of women having the Pap test. It is crucial to have new theory-based measurement tools with good reliability and validity to know reasons preventing women from having their first Pap smear testing. Since PMT is a useful guide to explain screening behaviors (e.g. cervical screening) (Abdullah et al., 2001) , it was considered as the theoretical framework for developing the measurement tool.
Given the necessity of developing a valid instrument to examine the factors influencing the women's intention to perform first Pap smear practice, the present study was designed to develop and validate an instrument to measure PMT variables associated with the women's intention to perform first Pap smear.
Materials and Methods
Study design
This psychometric research was conducted between July 2012 and December 2013 in Tehran, Iran.
Instrument development
Item generation; Several steps were followed for item generation procedures: 1) A review of the related literature; 2) Three focus group discussions were conducted with 30 women to explain their reasons for not receiving the Pap test. Women were recruited from primary health care clinics affiliated to Tehran University of Medical Sciences and never had a cervical screening; and 3) Interview with a panel of experts (Ten expert in health education, obstetrics, and gynecology) about the reasons and limitations of the Pap test in women. A 45-item instrument with 7 sub-scales (including perceived vulnerability, perceived severity, fear, response costs, response efficacy, self-efficacy, and intention) was generated and consequently, qualitative face and content validity of the items were evaluated (Table 1) .
Face validity; A group of women (n=30) were asked to reflect on the clarity simplicity, and readability of the items of the instrument (face validity). According to the participants' opinions, the ambiguous questions were revised and some minor wording errors were corrected. Content validity; Content validity of the instrument was evaluated quantitatively. The Content Validity Ratio (CVR) and the Content Validity Index (CVI) were calculated based on the experts' opinions. The expert panel was asked to judge the necessity and relevance of the scale items. Items with a CVR score of 0.62 and more (Lawshe, 1975) were selected. The CVI score of .80 (Polit and Beck, 2004) and above was considered satisfactory. Finally, 16 scale items were removed. The CVI and CVR of the total scale was 0.89 and 0.90, respectively in this study. The pre-final version of the instrument contained 29 items including 3 items on intention, 3 items on perceived vulnerability, 4 items on perceived severity, 3 items on fear, 5 items on response costs, 4 items on response efficacy, and 7 items on self-efficacy.
Construct validity; The construct validity of the scale was determined by Exploratory (EFA) and Confirmatory Factor Analysis (CFA). To calculate EFA and CFA, a sample of 240 women who were referred to 30 primary health care clinics affiliated to Tehran University of Medical Sciences was selected by the stratified random sampling method. The participants completed the questionnaire. Selection criteria were as follows: 1) not having the diagnosis of cervical cancer; 2) being married or sexually active; 3) negative history of the Pap test in the past; 4) negative history of full uterus hysterectomy; and 5) ability to read and write in Farsi. The study was approved by the ethics committee. All women were informed about the study objectives and a written consent was obtained.
EFA; Using the principal component analysis with varimax rotation an EFA was performed to determine the construct validity of the scale. The Bartlett's Test of Sphericity and Kaiser-Meyer-Olkin (KMO) were utilized to determine the appropriateness of the sample for factor analysis. Eigenvalues more than 1 and scree plot were utilized for choosing the number of factors. Factor loadings of 0.4 or above were considered acceptable (Nunnally and Bernstien, 1994) .
CFA; In this part of analysis, the data of 240 samples were used for evaluating the model fitness. All various fit indices including relative Chi-square (χ
Mean Square Error of Approximation (RMSEA), and Standardized Root Mean Square Residual (SRMR) were used (Mueller, 1996) . Relative Chi-square is obtained by division of chi-square to degrees of freedom and its recommended reference value is less than 3 for accepting the fitness of the model (Munro, 2005) . The values of CFI, IFI, NFI, and NNFI could range from 0 and 1 and values closer to 1 are indicative of data fitness (Kline, 2010 ). An RMSEA range from 0.8 to 0.10 shows a mediocre fit and values below 0.8 indicate a good fit (MacCallum, et al., 1996) . The acceptable value for SRMR is below 0.10 where values less than 0.8 indicate an adequate fit and values less than 0.5 indicate good fit (Bollen and Long, 1993; Hu and Bentler, 1999) .
Reliability; The scale internal consistency (Cronbach's Alpha coefficient) was calculated. Cronbach's Alpha of 0.70 and above was considered acceptable (Cronbach, 1951) . In order to determine the stability of the scale (Intraclass Correlation Coefficient), a sub-sample of women (n=30) completed the questionnaire twice with a 2-week interval. The ICC of 0.4 and above was considered satisfactory (Baumgartner and Chung, 2001 ).
Statistical analysis
Statistical analyses such as mean, standard deviations, and EFA were performed using the SPSS (version 17.0, SPSS, Inc., Chicago, IL, USA) software package and CFA was performed using the LISREL 8.80 for Windows (Joreskog and Sorbom, 2006 DOI:http://dx.doi.org/10.7314/APJCP.2014.15.3 
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Results
The mean age of the participants in the factor analysis was 38.12 years. Ninthly percent of them did not have a history of cancer in their family. Table 2 shows other demographic characteristics of participants in the factor analysis.
EFA
In this study, the KMO was 0.82 and the Bartlett's test of sphericity was significant (=3911.78, df=406, p<0.0001) showing that the data were good for factor analysis. The first analysis showed a 7-factor structure for the questionnaire with 3 items loading unexpectedly (1=strongly disagree to 2. I worry about having cervical cancer. 5=strongly agree). 3. In my relatives, no one has cervical cancer and neither do I. 4. There is a zero possibility for me to have cervical cancer. 5. Unless God desires, I will not have cervical cancer. 6. Only women beyond fifty years old will have cervical cancer.
Perceived Severity 1. Cervical cancer imposes high expenditure on me and my family.
10 items on a 5-point scale 2. If I have cervical cancer, my life will change.
(1=strongly disagree to 3. Cervical cancer limits me from having sex with my husband. 5=strongly agree). 4. If I have cervical cancer, I will die in five years. 5. I have not seen anybody dies because of cervical cancer. 6. If I take cervical cancer, I will not be able to do my daily activities. 7. Cervical cancer can be easily treated. 8. I'm afraid of thinking about cervical cancer. 9. When thinking about cervical cancer, I have a fast heartbeat. 10. The problems caused by cervical cancer remain for a long time. (1=strongly agree to 3. I fear that Pap smear confirms a problem in my reproduction organ. 5=strongly disagree).
Response Costs 1. The Pap test is not pleasant for me. 7 items on a 5-point scale 2. I am ashamed to have the Pap test.
(1=strongly agree to 3. As the Pap test requires repetition, it is hard for me to do it several times. 5=strongly disagree). 4. Because I think this test is done by males, I will not do it. 5. The Pap test poses a lot of financial problems on me. 6. I have not received any training for the Pap test by the health staff. 7. There are few centers that do the Pap test. Response Efficacy 1. The Pap test is effective in preventing cervical cancer.
7 items on a 5-point scale 2. The Pap test helps with early diagnosis of the disease.
(1=strongly disagree to 3. The Pap test prevents the spread of cervical cancer. 5=strongly agree). 4. Early diagnosis using the Pap test saves the patient's life. 5. Only in case I have done the Pap test, I can use some contraception devices such as IUD. 6. Upon receiving a negative result on the Pap test, I will be certain about the health of my reproduction organ. 7. After the Pap test, the health practitioner will confirm me. and irrelevant to the loaded construct. Thus, the 3 items were deleted from the analysis and a final 26-item scale loaded on 7 distinct constructs that commonly accounted for 72.76% of the observed variance. The range of factor loading of each item is shown in Table 3 .
CFA
The 26-item questionnaire was examined for confirmatory factor analysis. The relative chi-square (χ 2 /df) was 1.73, indicating the fitness of the model (p<0.0001). All comparative indices of the model including CFI, IFI, and NNFI were 0.9 and above (0.96, 0.96, 0.93 and 0.96, respectively) except for NFI (0.85), indicating the goodness of fit for the data. The RMSEA of the model was 0.5. The SRMR was less than 0.08 (0.06) confirming an acceptable fit for the model. The results of CFA are presented in Figure 1 .
Reliability
Cronbach's alpha (range, 0.70-0.93) and ICC (range, 0.72-0.96) of final version of the developed scale were acceptable. Cronbach's α coefficient (n=240) and ICC of subscales (n =30) are presented in Table 4 .
Discussion
In this study a 26-item scale with seven factors included perceived vulnerability and severity, fear, response costs, response efficacy, self-efficacy, and behavioral intention was developed. Our found that these seven variables mentioned above would affect on intention of Iranian women for performing first Pap testing. The results showed that developed instrument was a valid and reliable tool to detect these factors. There are a number of developed instruments for assessing such factors influence
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Pap testing (Linton and Porche, 2010; Luszczynska et al., 2011; Reis et al., 2012) , but, to best our knowledge was not developed similar questionnaire with the present study. For example, Linton et al. (Linton and Porche, 2010) developed a questionnaire based on Theory of Planned Behavior variables for determine intention of Pap smear among women in rural Southeast Louisiana. They reported that developed instrument was a valid and reliable tool. Totally, developing these instruments may be assist to educators in developing and evaluating theorybased education interventions regarding Pap testing. It is considering that theoretical frameworks demonstrate a road map for understanding different behavior of individuals (Jackson, 1997; Rimer and Glanz, 2005) . They may be assist practitioners recognize why individuals do or do not engage in specific health behaviors (Rimer and Glanz, 2005) .
Reliability
Our finding indicated that the developed instrument has good internal consistency and stability by having Cronbach α ranged from 0.70-0.93 and ICC ranged from 0.71 to 0.96, respectively. ICC results indicated that our designed instrument produces constant results from participants at different two times (with a 2-week interval). This results is consistent with Luszczynska et al. (Luszczynska et al., 2011) They was developed a instrument for determine the effectiveness a pros enhancing intervention in intention of women to uptake cervical cancer screening. In their study, Cronbach α for intention, pros and cons regarding Pap testing was 0.85, 0.86 and 0.71, respectively. In line with, Linton et al (2010) . reported that test-retest correlation and Cronbach α of their developed sub-scales ranged from 0.510 to 0.889 and 0.585 to 0.889, respectively. They also expressed that according to Munro comment (Munro, 2005) "when investigating the relationship among different aspects of human behavior" a correlation coefficient of 0.50 above is acceptable. In a study by Reis et al. (Reis et al., 2012) estimated Cronbach alpha for five subscales included benefits and barriers of pap smear, seriousness, susceptibility and health motivation was 0.86, 0.82, 0.78, 0.78 and 0.62, respectively.
Construct validity
The data of EFA and CFA analyses affirmed that developed scale has a suitable structure. EFA showed that the 7 factors structure of the designed instrument could jointly account for 72.76% of the variance. CFA indicated that factor structure of this scale was satisfactory as well. It can be argued that obtained good results might be the reason exactly selection of related items to discussed problem. It is considering that 3 items in related to response costs of Pap testing was deleted through factor analysis. Also, KMO equal to 0.82 and significant Bartlett's Test of Sphericity showed that samples were appropriate for the factor analysis. The fitness of the model was shown using relative chi-square equal to 1.73. In line with, Bazarganipour et al. (Bazarganipour et al., 2012) . showed that CFA for Iranian version of modified polycystic ovary syndrome health-related quality-of-life questionnaire (MPCOSQ) was acceptable fit. They also reported that six-factor solutions (included emotional problems, weight, acne, infertility, hirsutism and menstrual difficult) explained 0.64% of the variance observed. This results is in agreement with Naderimagham et al. (2012) . and Montazeri et al., 2009) .
Content validity
In this study, was used of panel expert opinions for measuring quantitative content validity and evaluated CVI and CVR of designed scale. Rubio et al. (2003) suggested that the experts' opinions are best methods for evaluating content validity. According to literature, a satisfactory CVR and CVI values for 10 expert panels are 0.62 and 0.80. (Lawshe, 1975; Polit and Beck, 2004) . In the present study, CVI and CVR of designed scale was 0.89 and 0.90, respectively. In the developed scale by Linton et al. the CVI of scale was 0.84 (Linton and Porche, 2010) .
Although the present findings highlight the utility of PMT-guided framework to develop theory-based instrument regarding Pap testing, it had a limitation. Limitation of the present study was data was collected of a sample of women referral to primary health care clinics affiliated to Tehran University of Medical Sciences. It is considering that, these clinics were in low-income areas of Tehran, Iran. This homogeneity of samples may limit the extent to which findings can be generalised to other women residing in high and middle-income areas of Tehran. More researches to utility of this scale in explaining implications of Pap testing within other racial/ ethnic groups and geographic areas in Iran are needed.
In conclusion,the study confirmed that the developed scale was a valid and reliable tool for use in the Iranian population. This instrument can help educators explore evidence-based priorities for increasing first Pap testing among women and developing tailored interventions.
